JP3526806B2 - Cosmetics - Google Patents
CosmeticsInfo
- Publication number
- JP3526806B2 JP3526806B2 JP2000089577A JP2000089577A JP3526806B2 JP 3526806 B2 JP3526806 B2 JP 3526806B2 JP 2000089577 A JP2000089577 A JP 2000089577A JP 2000089577 A JP2000089577 A JP 2000089577A JP 3526806 B2 JP3526806 B2 JP 3526806B2
- Authority
- JP
- Japan
- Prior art keywords
- salt
- solution
- skin
- skin cosmetic
- cell growth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000002537 cosmetic Substances 0.000 title claims description 39
- 150000003839 salts Chemical class 0.000 claims description 42
- 230000010261 cell growth Effects 0.000 claims description 23
- 239000000243 solution Substances 0.000 claims description 20
- 230000001737 promoting effect Effects 0.000 claims description 19
- 239000013535 sea water Substances 0.000 claims description 13
- 239000002244 precipitate Substances 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 238000004519 manufacturing process Methods 0.000 claims description 9
- 239000003637 basic solution Substances 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 8
- 238000001704 evaporation Methods 0.000 claims description 7
- 238000001914 filtration Methods 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 230000003712 anti-aging effect Effects 0.000 claims description 4
- 239000007864 aqueous solution Substances 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 210000003491 skin Anatomy 0.000 description 28
- 230000037303 wrinkles Effects 0.000 description 17
- 239000000203 mixture Substances 0.000 description 12
- 230000000694 effects Effects 0.000 description 11
- 230000000052 comparative effect Effects 0.000 description 10
- 239000006071 cream Substances 0.000 description 10
- 239000006210 lotion Substances 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- -1 pack Substances 0.000 description 6
- 239000002994 raw material Substances 0.000 description 6
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 5
- 238000007796 conventional method Methods 0.000 description 5
- 239000008213 purified water Substances 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 4
- 235000019441 ethanol Nutrition 0.000 description 4
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 4
- 239000002304 perfume Substances 0.000 description 4
- 230000009759 skin aging Effects 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 210000000434 stratum corneum Anatomy 0.000 description 4
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 3
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 3
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 3
- 239000004909 Moisturizer Substances 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 206010040844 Skin exfoliation Diseases 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 210000002744 extracellular matrix Anatomy 0.000 description 3
- 230000007794 irritation Effects 0.000 description 3
- 230000001333 moisturizer Effects 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 102000016942 Elastin Human genes 0.000 description 2
- 108010014258 Elastin Proteins 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 210000003298 dental enamel Anatomy 0.000 description 2
- 229920002549 elastin Polymers 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 229940099259 vaseline Drugs 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- AZKSAVLVSZKNRD-UHFFFAOYSA-M 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide Chemical compound [Br-].S1C(C)=C(C)N=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=CC=C1 AZKSAVLVSZKNRD-UHFFFAOYSA-M 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 241001237961 Amanita rubescens Species 0.000 description 1
- 101000645291 Bos taurus Metalloproteinase inhibitor 2 Proteins 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 229940122097 Collagenase inhibitor Drugs 0.000 description 1
- 244000247747 Coptis groenlandica Species 0.000 description 1
- 235000002991 Coptis groenlandica Nutrition 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 101000669513 Homo sapiens Metalloproteinase inhibitor 1 Proteins 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 102100039364 Metalloproteinase inhibitor 1 Human genes 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 description 1
- 102000016387 Pancreatic elastase Human genes 0.000 description 1
- 108010067372 Pancreatic elastase Proteins 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 238000011481 absorbance measurement Methods 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 description 1
- 229960003321 baicalin Drugs 0.000 description 1
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 description 1
- 239000013040 bath agent Substances 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 229940008396 carrot extract Drugs 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 239000002442 collagenase inhibitor Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000004299 exfoliation Methods 0.000 description 1
- 210000004709 eyebrow Anatomy 0.000 description 1
- 230000008921 facial expression Effects 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 239000000118 hair dye Substances 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 235000020721 horse chestnut extract Nutrition 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 239000007934 lip balm Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940078752 magnesium ascorbyl phosphate Drugs 0.000 description 1
- 229940039092 medicated shampoos Drugs 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- WNIFXKPDILJURQ-JKPOUOEOSA-N octadecyl (2s,4as,6ar,6as,6br,8ar,10s,12as,14br)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1h-picene-2-carboxylate Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@](C(=O)OCCCCCCCCCCCCCCCCCC)(C)C[C@H]5C4=CC(=O)[C@@H]3[C@]21C WNIFXKPDILJURQ-JKPOUOEOSA-N 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000008257 shaving cream Substances 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- HTJNEBVCZXHBNJ-XCTPRCOBSA-H trimagnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;diphosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O HTJNEBVCZXHBNJ-XCTPRCOBSA-H 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Cosmetics (AREA)
Description
【0001】[0001]
【発明の属する技術分野】本発明は、海水から得られた
塩を含有することにより、しわや、しみ等の皮膚の老化
を防止する作用、または、細胞増殖促進作用を有する化
粧料に関する。TECHNICAL FIELD The present invention relates to a cosmetic composition containing a salt obtained from seawater to prevent skin aging such as wrinkles and spots, or to promote cell growth.
【0002】[0002]
【従来の技術】人の皮膚は加齢に伴って徐々に老化する
が、加齢以外にも様々な外的刺激が、皮膚老化の原因と
なることが知られている。特に日光中の紫外線は、細胞
外マトリックスの構成成分であるコラーゲン、エラスチ
ンなどの架橋や切断を生じさせ、それにより肌の弾力性
や保湿性を低下させてしまうため、しわ、乾燥肌、荒れ
性などの原因となる。このような変化を受けた肌はさら
に外的刺激をうけやすくなり、細胞の活動が低下し、細
胞外マトリックスの再生力が減退するという悪循環に陥
って老化が急激に進行する。短期間に進行する肌のつや
の消失、しみ、くすみ等の増加は、上述のような強い外
的刺激に起因するものが多い。そのため、外的刺激によ
る皮膚老化を防止するために、紫外線吸収剤や保湿剤を
化粧料に配合することが行われてきた。2. Description of the Related Art Human skin gradually ages with aging, and it is known that various external stimuli other than aging cause skin aging. In particular, ultraviolet rays in sunlight cause cross-linking or cutting of collagen, elastin, etc., which are components of the extracellular matrix, and thereby reduce the elasticity and moisturizing properties of the skin, resulting in wrinkles, dry skin, and rough skin. Cause of. Skin that has undergone such changes is more susceptible to external stimuli, cell activity is reduced, and the regenerative capacity of the extracellular matrix is reduced. The loss of skin gloss, the increase in stains, dullness, etc., which progresses in a short period of time, is often due to the strong external stimulus as described above. Therefore, in order to prevent skin aging due to external irritation, ultraviolet absorbers and moisturizers have been incorporated into cosmetics.
【0003】また、化粧料にコラゲナーゼやエラスター
ゼを阻害する成分を配合して細胞外マトリックスを正常
状態に維持しようとしたり、ビタミンCや、ビタミンE
のような細胞増殖促進作用のある成分を配合することも
行われてきた。In addition, cosmetics are blended with ingredients that inhibit collagenase and elastase to try to maintain the extracellular matrix in a normal state, and vitamin C and vitamin E.
It has also been carried out to incorporate a component having a cell growth promoting action such as.
【0004】しかしながら、通常配合し得る程度の紫外
線吸収剤で有害紫外線を完全に遮断することは難しく、
あえて多量に配合すれば皮膚に対する刺激性が問題とな
る。保湿剤やコラゲナーゼ阻害剤等で皮膚細胞を十分活
性化することも困難であり、ビタミンC等の細胞増殖促
進成分は安全性、安定性等に問題があり、必ずしも満足
できるものではなかった。However, it is difficult to completely block harmful ultraviolet rays with an ultraviolet absorber that can be usually mixed,
If added in a large amount, irritation to the skin becomes a problem. It is also difficult to sufficiently activate skin cells with a moisturizer, a collagenase inhibitor, etc., and a cell growth promoting component such as vitamin C has problems in safety, stability, etc., and it was not always satisfactory.
【0005】[0005]
【発明が解決しようとする課題】本発明の目的は、海水
から得られる塩を含有し、しわ、しみ等の皮膚の老化を
防止し、細胞増殖を促すことにより、刺激性が少なく、
安全性の高い化粧料を提供することである。The object of the present invention is to contain a salt obtained from seawater, prevent skin aging such as wrinkles and spots, and promote cell proliferation, thereby reducing irritation.
It is to provide cosmetics with high safety.
【0006】[0006]
【課題を解決するための手段】本発明者らは、上記の問
題点を解決すべく鋭意検討した結果、老化防止作用、及
び/または、細胞増殖促進作用を有する本発明に係る化
粧料を完成させるに至った。Means for Solving the Problems As a result of intensive studies to solve the above problems, the present inventors have completed a cosmetic composition according to the present invention having an antiaging effect and / or a cell growth promoting effect. Came to let.
【0007】[0007]
【0008】請求項1は、海水を酸性にした後、塩基性
溶液を加え、生成する沈殿物を除去した後、得られた溶
液を濃縮し、冷却後、濾別することにより得られる塩
(B)と、濾別された溶液から溶媒を蒸発することによ
り得られる塩(C)との、少なくとも何れか一方を含有
する皮膚用化粧料に関する。According to the first aspect of the present invention, after salt water is acidified, a basic solution is added to remove precipitates formed, the resulting solution is concentrated, cooled and filtered to obtain a salt ( It relates to a skin cosmetic containing at least one of B) and a salt (C) obtained by evaporating a solvent from the filtered solution.
【0009】[0009]
【0010】請求項2は、海水を酸性にした後、塩基性
溶液を加え、生成する沈殿物を除去した後、得られた溶
液を濃縮し、冷却後、濾別することにより得られる塩
(B)と、濾別された溶液から溶媒を蒸発することによ
り得られる塩(C)との、少なくとも何れか一方を水に
溶解させた水溶液を含有する皮膚用化粧料に関する。According to a second aspect of the present invention, the salt obtained by acidifying seawater, adding a basic solution to remove the formed precipitate, concentrating the obtained solution, cooling and filtering the salt ( The present invention relates to a skin cosmetic containing an aqueous solution in which at least one of B) and a salt (C) obtained by evaporating a solvent from a filtered solution is dissolved in water.
【0011】[0011]
【0012】請求項3は、前記塩(B)及び前記塩
(C)の双方の合計量が、0.1乃至2.0重量%含有
することを特徴とする皮膚用化粧料に関する。A third aspect of the present invention relates to a skin cosmetic , wherein the total amount of both the salt (B) and the salt (C) is 0.1 to 2.0% by weight.
【0013】請求項4は、老化防止作用及び細胞増殖促
進作用の少なくとも何れか一方を有することを特徴とす
る皮膚用化粧料に関する。A fourth aspect of the present invention relates to a cosmetic for skin, which has at least one of an antiaging effect and a cell growth promoting effect.
【0014】本発明の化粧料は、ローション、乳液、ク
リーム、パック、ジェル状化粧料、パウダー化粧料、石
鹸、液状洗浄剤など、皮膚に適用される任意の化粧料の
形態をとることができる。The cosmetic of the present invention can be in the form of any cosmetic applied to the skin, such as lotion, emulsion, cream, pack, gel cosmetic, powder cosmetic, soap and liquid detergent. .
【0015】また、本発明における化粧料とは、薬事法
で定めるところの医薬部外品のうち育毛剤、浴用剤、薬
用化粧料、薬用化粧品即ち薬用石鹸、薬用シャンプー、
薬用リンス、薬用化粧水、薬用クリーム・乳液、薬用パ
ック、染毛料、頭髪用化粧品、一般クリーム・乳液、ひ
げそり用クリームまたはローション、日焼け・日焼け止
めローション、化粧油、軟膏、日焼け・日焼け止めオイ
ル、白粉、パウダー、ファンデーション、香水、パッ
ク、爪クリーム、エナメル、エナメル除去剤、眉墨、頬
紅、アイクリーム、アイシャドー、マスカラ、アイライ
ナー、口紅、リップクリーム、はみがき、浴用化粧品な
どに応用できる。Further, the cosmetics in the present invention include hair growth agents, bath agents, medicated cosmetics, medicated cosmetics, that is, medicated soaps, medicated shampoos, among quasi drugs prescribed by the Pharmaceutical Affairs Law.
Medicated rinse, medicated lotion, medicated cream / milky lotion, medicated pack, hair dye, cosmetics for hair, general cream / milky lotion, shaving cream or lotion, suntan / sunblock lotion, cosmetic oil, ointment, suntan / sunblock oil, It can be applied to white powder, powder, foundation, perfume, pack, nail cream, enamel, enamel remover, eyebrow, blusher, eye cream, eye shadow, mascara, eyeliner, lipstick, lip balm, toothpaste and bath cosmetics.
【0016】本発明の化粧料は、その化粧料の製造に通
常使用される構成成分、たとえば、油分、界面活性剤、
増粘剤、保湿剤、防腐剤、香料、着色料、キレート剤、
アミノ酸、糖類などを1種又は、2種以上含有するもの
であってもよい。The cosmetic of the present invention comprises the constituents usually used in the production of the cosmetic, such as oil, surfactant,
Thickener, moisturizer, preservative, fragrance, colorant, chelating agent,
It may contain one or more amino acids and sugars.
【0017】さらに、本発明の化粧料には、必要に応じ
て、任意の量のグリチルリチン酸、若しくはその塩、若
しくはその誘導体(グリチルレチン酸ステアリルな
ど)、アラントイン、アズレン、バイカリン、マロニエ
抽出物、オウバク抽出物、オウレン抽出物、アスコルビ
ン酸、アスコルビン酸リン酸マグネシウム、エラグ酸、
アルブチン、コウジ酸、プラセンターエキス、桑白皮
酸、クジン抽出物、ワレモコウ抽出物、エイジツ抽出
物、ビタミン類、トコフェロールおよびその誘導体、天
然ビタミンE、コラーゲン、エラスチン・ヒアルロン
酸、コンドロイチン硫酸から選ばれる1種又は2種以上
の成分を含有するものであってもよい。Further, the cosmetic composition of the present invention contains, if necessary, any amount of glycyrrhizinic acid, or a salt thereof, or a derivative thereof (stearyl glycyrrhetinate, etc.), allantoin, azulene, baicalin, horse chestnut extract, and auburn. Extract, Coptis extract, Ascorbic acid, Magnesium ascorbyl phosphate, Ellagic acid,
Arbutin, kojic acid, placenta extract, mulberry acid, kujin extract, waremout extract, age extract, vitamins, tocopherol and its derivatives, natural vitamin E, collagen, elastin hyaluronic acid, chondroitin sulfate It may contain one or more components.
【0018】[0018]
【0019】請求項5は、皮膚用化粧料の含有成分であ
る塩(B)または塩(C)を製造する方法であって、海
水を酸性にする第一の過程と、塩基性溶液を加え、生成
する沈殿物を除去する第二の過程と、前記第二の過程に
おいて得られた溶液を、濃縮し、冷却後、濾別すること
により得られる前記塩(B)を生成し、または、濾別さ
れた溶液から溶媒を蒸発することにより得られる前記塩
(C)を生成する第三の過程と、を備える、皮膚用化粧
料の含有成分である塩(B)または塩(C)の製造方法
を提供する。A fifth aspect of the present invention is a method for producing salt (B) or salt (C) which is a component of a skin cosmetic composition, which comprises adding a first step of acidifying seawater and a basic solution. A second step of removing the produced precipitate and the solution obtained in the second step are concentrated, cooled, and then filtered to form the salt (B), or comprising a third step of generating the salts obtained (C) by evaporation of the solvent from the filtered solution the the cosmetic skin
Providing fee manufacturing method of containing component is a salt (B) or salt (C) of.
【0020】[0020]
【0021】請求項6は、皮膚用化粧料の製造方法であ
って、海水を酸性にする第一の過程と、塩基性溶液を加
え、生成する沈殿物を除去する第二の過程と、前記第二
の過程において得られた溶液を、濃縮し、冷却後、濾別
することにより得られる塩(B)を生成し、または、濾
別された溶液から溶媒を蒸発することにより得られる塩
(C)を生成する第三の過程と、前記塩(B)および前
記塩(C)の少なくとも何れか一方を皮膚用化粧料に含
有させる第四の過程と、を備える皮膚用化粧料の製造方
法を提供する。[0021] A sixth aspect of the present invention is a method for producing a skin cosmetic , comprising a first step of acidifying seawater, a second step of adding a basic solution and removing a precipitate formed, and The solution obtained in the second step is concentrated and cooled, and then filtered to produce a salt (B), or a salt obtained by evaporating a solvent from the filtered solution ( third process and, at least one method for producing a skin cosmetic comprising a fourth step, the to one of the contained in the skin cosmetic of the salt (B) and the salts (C) to produce a C) I will provide a.
【0022】[0022]
【発明の実施の形態】以下に実施例をあげて本発明を更
に詳細に説明するが、下記実施例は本発明を制限するも
のではない。BEST MODE FOR CARRYING OUT THE INVENTION The present invention will be described in more detail with reference to the following examples, but the following examples do not limit the present invention.
【0023】海水500リットルに対し、リン酸カルシ
ウムを溶解させた水溶液に5%の濃硫酸を加えて沈殿物
を除去した水溶液10リットルを加え、3時間放置した
後、不溶物を濾過により除去した。これにより海水はp
H1.6となった。次に、低pH化した海水500リッ
トルに水酸化ナトリウムを15キログラム加え、10時
間放置した。この時、生成した沈殿物を濾別し、残った
海水10リットルを加熱して水分を除去し1.5リット
ルの濃縮溶液とした。この濃縮溶液を急冷させて沈殿物
を生ぜしめ、濾別することにより得られる塩(B)と、
濾別後の溶液を乾燥することにより得られる塩(C)と
を、合わせて200グラム得た。この塩(B)及び塩
(C)の混合物(以下、「細胞増殖促進物質」とい
う。)100グラムを水に溶解させることにより原液を
得た。To 500 liters of seawater, 10 liters of an aqueous solution prepared by dissolving calcium phosphate in which 5% concentrated sulfuric acid was added to remove precipitates was added, and the mixture was allowed to stand for 3 hours and then insoluble matters were removed by filtration. This makes seawater p
It became H1.6. Next, 15 kg of sodium hydroxide was added to 500 liters of seawater having a lowered pH, and the mixture was left for 10 hours. At this time, the formed precipitate was filtered off, and 10 liters of the remaining seawater was heated to remove water, thereby obtaining a 1.5 liter concentrated solution. The concentrated solution is rapidly cooled to form a precipitate, and the salt (B) obtained by filtering is removed;
A total of 200 g of the salt (C) obtained by drying the solution after separation by filtration was obtained. A stock solution was obtained by dissolving 100 g of a mixture of the salt (B) and the salt (C) (hereinafter referred to as "cell growth promoting substance") in water.
【0024】[0024]
【実施例1〜3】、[Examples 1 to 3],
【比較例1〜2】下記(イ)〜(ハ)を原料として、常
法により化粧料を製造した。
(イ)(1)ジプロピレングリコール 4重量%
(2)1、3―ブチレングリコール 2
(3)ポリオキシエチレン(60)硬化ヒマシ油 1
(4)エチルアルコール 4
(5)パラオキシ安息香酸メチル 0.1
(6)クエン酸 0.2
(7)クエン酸ソーダ 0.1
(8)香料 0.02
(ロ) 表1参照
(ハ) 精製水で、全量を100とする。[Comparative Examples 1 and 2] Using the following (a) to (c) as raw materials, cosmetics were produced by a conventional method. (A) (1) 4% by weight of dipropylene glycol (2) 1,3-butylene glycol 2 (3) polyoxyethylene (60) hydrogenated castor oil 1 (4) ethyl alcohol 4 (5) methyl paraoxybenzoate 1 (6) Citric acid 0.2 (7) Sodium citrate 0.1 (8) Perfume 0.02 (b) See Table 1 (c) Purified water to 100 in total.
【0025】[0025]
【表1】 [Table 1]
【0026】[0026]
【試験例1】実施例1〜3及び比較例1〜2の化粧水に
ついて、下記MTT法により細胞増殖促進作用を試験し
た。[Test Example 1] The lotions of Examples 1 to 3 and Comparative Examples 1 and 2 were tested for cell growth promoting action by the following MTT method.
【0027】MTT法(J.immunol.Method 93,157.198
6):前培養を行ったヒト正常新生児皮膚繊維芽細胞(N
B1RGB)を96穴マイクロプレートに分注し、試料を溶
解した10%FBS培養液添加RITC80-7培地(極東製薬社
製品、pH7.2)を加え、5%CO2下、37℃で3
日間培養する。次いで、MTT試薬(3-(4,5-dimethyl-2
-thiazolyl)-2,5-diphenyl-2H tetrazolium bromide,5m
g/ml)20μlを添加し、4.5時間インキュベーショ
ンする(増殖した細胞中のミトコンドリア由来の活性酵
素がMTT試薬と反応し、黄色であった試薬の色が57
0mmに吸収のピークを有する青黄色に変わる)。その
後、マイクロプレートリーダーを用いて570mmの吸光
度(A)を測定する。別に、試料を添加せずに同様の培
養を行い、吸光度(B)を測定する。さらに、試料を添
加し、細胞を添加しないで同様の処理を行った場合の吸
光度(C)を測定する。最後に、試料も細胞も添加しな
いで同様の処理を行った場合の吸光度(D)も測定す
る。MTT method (J.immunol.Method 93,157.198
6): Precultured normal human neonatal dermal fibroblasts (N
B1RGB) was dispensed into a 96-well microplate, RITC80-7 medium (Kyoto Pharmaceutical Co., Ltd., pH 7.2) containing 10% FBS culture solution in which the sample was dissolved was added, and the mixture was mixed at 37 ° C. under 5% CO 2 for 3 days.
Incubate for a day. Then, MTT reagent (3- (4,5-dimethyl-2
-thiazolyl) -2,5-diphenyl-2H tetrazolium bromide, 5m
20 μl of g / ml) is added and incubated for 4.5 hours (active mitochondria-derived active enzyme in the grown cells reacts with the MTT reagent, and the color of the reagent which was yellow is 57
It turns blue-yellow with an absorption peak at 0 mm). Then, the absorbance (A) at 570 mm is measured using a microplate reader. Separately, the same culture is performed without adding the sample, and the absorbance (B) is measured. Further, the absorbance (C) when the sample is added and the same treatment is performed without adding the cells is measured. Finally, the absorbance (D) when the same treatment is performed without adding the sample and the cells is also measured.
【0028】各吸光度測定値は、同時に測定した650
mmの吸光度を差し引いて、増殖した細胞による濁度上昇
の影響を補正する。補正後の各吸光度より次式により細
胞増殖促進率を求める。
細胞増殖促進率(%)=[{(A−C)−(B−D)}
/(B−D)]×100
結果は表2に示したとおりで、全実施例の化粧水につい
て細胞増殖促進作用が確認され、特に実施例1乃至3の
化粧水については極めて優れた細胞増殖促進作用が確認
された。しかし、比較例1〜2の化粧水は細胞増殖促進
作用が見られなかった。Each absorbance measurement value was 650 measured at the same time.
The absorbance in mm is subtracted to correct for the effects of increased turbidity due to grown cells. From each corrected absorbance, the cell growth promotion rate is calculated by the following formula. Cell growth promotion rate (%) = [{(AC)-(BD)}
/ (BD)] × 100 The results are shown in Table 2, and the cell growth-promoting action was confirmed for the lotions of all Examples, and particularly the cell growth of the lotions of Examples 1 to 3 was extremely excellent. A promoting effect was confirmed. However, the lotions of Comparative Examples 1 and 2 did not show a cell growth promoting action.
【0029】[0029]
【表2】 細胞増殖促進率(%)
(注:「試料濃度」は培地1における試料濃度であ
る。)[Table 2] Cell growth promotion rate (%) (Note: “Sample concentration” is the sample concentration in Medium 1.)
【0030】[0030]
【実施例4】下記の原料を常法により処理してクリーム
を製造した。
(1)細胞増殖促進物質 2.0
(2)アセトステアリルアルコール 3.5
(3)スクワラン 30.0
(4)ミツロウ 3.0
(5)還元ラノリン 5.0
(6)パラオキシ安息香酸ステアリル 0.1
(7)ポリオキシエチレン(20)モノステアリン酸ソルビタン 2.0
(8)グリセリンモノステアリン酸エステル 5.0
(9)1,3−ブチレングリコール 5.0
(10)香料 0.05
(11)精製水で、全量を100とする。Example 4 A cream was produced by treating the following raw materials by a conventional method. (1) Cell growth promoting substance 2.0 (2) Acetostearyl alcohol 3.5 (3) Squalane 30.0 (4) Beeswax 3.0 (5) Reduced lanolin 5.0 (6) Stearyl paraoxybenzoate 0. 1 (7) Polyoxyethylene (20) sorbitan monostearate 2.0 (8) Glycerin monostearate 5.0 (9) 1,3-butylene glycol 5.0 (10) Perfume 0.05 (11) Make up to 100 with purified water.
【0031】[0031]
【比較例3】実施例4の原料から細胞増殖促進物質を除
いてクリームを製造した。Comparative Example 3 A cream was produced by removing the cell growth promoting substance from the raw material of Example 4.
【0032】[0032]
【試験例2】肌のクスミ、シワ、乾燥症を訴える女性1
8名(年齢33〜45歳:下記の判定基準で2項目とも
評点1〜2の者)をパネラーとして、実施例4および比
較例3のクリームについて下記の使用試験を行なった。[Test Example 2] A woman who complains of skin dullness, wrinkles, and dryness 1
The following use tests were carried out on the creams of Example 4 and Comparative Example 3 with 8 persons (ages 33 to 45 years old: persons having a score of 1 to 2 for both items according to the following criteria) as panelists.
【0033】試験法:パネラーを9名ずつの2群に分
け、その一方には実施例4のクリームを、他方には比較
例3のクリームを、それぞれ50日間、毎日朝夕2回、
顔面に塗布させた。50日後、塗布面のツヤ、クスミお
よびカサツキ、ならびにシワの数および深さを肉眼で観
察させ、下記の判定基準による評点で回答させた。〔肌
のツヤ・クスミおよびカサツキ〕
評点 観察結果
1 肌のツヤが全く無く、クスミが強い。角層の剥離
が多く観察される。
2 肌のツヤが全く無く、全体にクスミがあり、角層
の剥離が所々に見られる。
3 肌ツヤがややあり、クスミが見られない。角層は
肉眼では剥がれていないが、化粧綿で軽くこすると剥離
する。
4 肌にツヤがあり、ハリもある。化粧綿でこすって
も角層の剥離がほとんどない。
〔シワ〕
評点 観察結果
1 目尻のシワが深く、数多く見られる。
2 目尻のシワが見られ、数もやや多い。
3 目尻のシワが認められるが数は少ない。
4 通常の表情のときは目尻のシワが認められない。
試験結果を表3、表4に示す。Test method: The panelists were divided into 2 groups of 9 persons, one of which was the cream of Example 4 and the other was the cream of Comparative Example 3 for 50 days each twice a day in the morning and evening.
It was applied to the face. After 50 days, the number and depth of gloss, wrinkles and dryness, and wrinkles on the coated surface were observed with the naked eye, and answers were given according to the following criteria. [Skin gloss and dullness] Rating Observation result 1 No skin gloss and strong dullness. Many exfoliations of the stratum corneum are observed. 2 There is no gloss on the skin, there is dullness on the whole, and peeling of the stratum corneum can be seen in places. 3 There is slight gloss on the skin and no dullness is visible. The stratum corneum is not peeled off with the naked eye, but it is peeled off when lightly rubbed with a cotton swab. 4 The skin is shiny and firm. Almost no peeling of the stratum corneum even with rubbing with makeup cotton [Wrinkles] Rating Observation result 1 There are many wrinkles around the corners of the eyes, and many are seen. Wrinkles around the 2nd corner are seen, and the number is slightly large. 3 Wrinkles around the outer corner of the eye are observed, but the number is small. 4 Wrinkles around the corners of the eyes are not recognized under normal facial expression. The test results are shown in Tables 3 and 4.
【0034】[0034]
【表3】 肌のツヤ、クスミおよびカサツキの改善効果 [Table 3] Effect of improving skin gloss, dullness and dryness
【0035】[0035]
【表4】 シワの改善効果 [Table 4] Wrinkle improvement effect
【0036】[0036]
【実施例5】下記組成の乳液を常法により製造した。 (1) 細胞増殖促進物質 2.0 (2) ニンジン抽出液 0.065 (3) セチルアルコール 0.5 (4) スクワラン 3.0 (5) ミツロウ 1.0 (6) ワセリン 2.0 (7) ポリオキシエチレン(20)モノオレイン酸ソルビタン 1.0 (8) グリセリンモノステアリン酸エステル 1.0 (9) ジプロピレングリコール 4.0 (10) エタノール 2.0 (11) バラオキシ安息香酸メチル 0.12 (12) ヒアルロン酸ナトリウム 0.1 (13) 精製水で、全量を100とする。Example 5 An emulsion having the following composition was produced by a conventional method. (1) Cell growth promoting substance 2.0 (2) Carrot extract 0.065 (3) Cetyl alcohol 0.5 (4) Squalane 3.0 (5) Beeswax 1.0 (6) Vaseline 2.0 (7) Polyoxyethylene (20) sorbitan monooleate 1.0 (8) Glycerin monostearate 1.0 (9) Dipropylene glycol 4.0 (10) Ethanol 2.0 (11) Methyl roseoxybenzoate 0.12 (12) Sodium hyaluronate 0.1 (13) The total amount is 100 with purified water.
【0037】[0037]
【比較例4】実施例5の原料から細胞増殖促進物質を除
いて乳液を製造した。Comparative Example 4 An emulsion was prepared by removing the cell growth promoting substance from the raw material of Example 5.
【0038】[0038]
【試験例3】試験例2と同様の試験を行った。試験結果
を、表5、表6に示す。[Test Example 3] The same test as in Test Example 2 was performed. The test results are shown in Tables 5 and 6.
【0039】[0039]
【表5】 肌のツヤ、クスミおよびカサツキの改善効果 [Table 5] Improvement effect on gloss, dullness and dryness of skin
【0040】[0040]
【表6】 シワの改善効果 [Table 6] Wrinkle improvement effect
【0041】[0041]
【実施例6】下記組成のパックを常法により製造した。 (1)細胞増殖促進物質 1.0 (2) ポリビニルアルコール 15.0 (3) ポリエチレングリコール 3.0 (4) プロピレングリコール 7.0 (5) エタノール 10.0 (6) メチルパラベン 0.05 (7) 香料 0.05 (8) 精製水で、全量を100とする。Example 6 A pack having the following composition was produced by a conventional method. (1) Cell growth promoting substance 1.0 (2) Polyvinyl alcohol 15.0 (3) Polyethylene glycol 3.0 (4) Propylene glycol 7.0 (5) Ethanol 10.0 (6) Methylparaben 0.05 (7) Perfume 0.05 (8) Make up to 100 with purified water.
【0042】[0042]
【比較例5】実施例6の原料から細胞増殖促進物質を除
いてパックを製造した。Comparative Example 5 A pack was produced by removing the cell growth promoting substance from the raw material of Example 6.
【0043】[0043]
【試験例4】試験例2と同様の試験を行った。試験結果
を、表7、表8に示す。[Test Example 4] The same test as in Test Example 2 was performed. The test results are shown in Tables 7 and 8.
【0044】[0044]
【表7】 肌のツヤ、クスミおよびカサツキの改善効果 [Table 7] Improvement effect on gloss, dullness and dryness of skin
【0045】[0045]
【表8】 シワの改善効果 [Table 8] Wrinkle improvement effect
【0046】[0046]
【実施例7】下記組成の軟膏を常法により製造した。 (1) 細胞増殖促進物質 0.5 (2) セチルアルコール 18.0 (3) モクロウ 20.0 (4) ポリオキシエチレン(20)モノオレイン酸エステル 0.25 (5) グリセリンモノステアリン酸エステル 0.25 (6) ワセリン 40.0 (7) 精製水で、全量を100とする。Example 7 An ointment having the following composition was produced by a conventional method. (1) Cell growth promoting substance 0.5 (2) Cetyl alcohol 18.0 (3) Mokurou 20.0 (4) Polyoxyethylene (20) monooleate 0.25 (5) Glycerin monostearate 0.25 (6) Vaseline 40.0 (7) The total amount is 100 with purified water.
【0047】[0047]
【比較例6】実施例7の原料から細胞増殖促進物質を除
いて軟膏を製造した。Comparative Example 6 An ointment was produced by removing the cell growth promoting substance from the raw material of Example 7.
【0048】[0048]
【試験例5】試験例2と同様の試験を行った。試験結果
を、表9、表10に示す。[Test Example 5] The same test as in Test Example 2 was performed. The test results are shown in Tables 9 and 10.
【0049】[0049]
【表9】 肌のツヤ、クスミおよびカサツキの改善効果 [Table 9] Improvement effect on gloss, dullness and dryness of skin
【0050】[0050]
【表10】 シワの改善効果 [Table 10] Wrinkle improvement effect
【0051】以上の試験結果3〜5から、実施例5〜7
のいずれの実施例品も、細胞増殖促進物質を含んでいな
い比較例品4〜6よりも、極めて優れたつや、しみ、し
わ、くすみなどの皮膚改善効果が見られた。From the above test results 3 to 5, Examples 5 to 7 were obtained.
In all of the example products, the skin improving effects such as gloss, stains, wrinkles, and dullness were observed as compared with Comparative example products 4 to 6 containing no cell growth promoting substance.
【0052】[0052]
【発明の効果】本発明によれば、細胞増殖促進作用、老
化防止作用が認められ、しみ、しわ、くすみなどの皮膚
の改善に有効である化粧料が提供される。INDUSTRIAL APPLICABILITY According to the present invention, there is provided a cosmetic composition which has cell growth promoting action and anti-aging action and is effective in improving skin such as spots, wrinkles and dullness.
フロントページの続き (56)参考文献 特開 平11−12154(JP,A) 特開 平10−182412(JP,A) 特開 平10−182347(JP,A) 特開 平8−217631(JP,A) 特開 平8−104607(JP,A) 特開2000−72656(JP,A) 特開 平7−17850(JP,A) 特開 平6−256161(JP,A) 特開 平10−194732(JP,A) 特開 平8−91829(JP,A) (58)調査した分野(Int.Cl.7,DB名) A61K 7/00 - 7/50 Continuation of the front page (56) Reference JP-A-11-12154 (JP, A) JP-A-10-182412 (JP, A) JP-A-10-182347 (JP, A) JP-A-8-217631 (JP , A) JP 8-104607 (JP, A) JP 2000-72656 (JP, A) JP 7-17850 (JP, A) JP 6-256161 (JP, A) JP 10 -194732 (JP, A) JP-A-8-91829 (JP, A) (58) Fields investigated (Int.Cl. 7 , DB name) A61K 7/ 00-7/50
Claims (6)
え、生成する沈殿物を除去した後、得られた溶液を濃縮
し、冷却後、濾別することにより得られる塩(B)と、
濾別された溶液から溶媒を蒸発することにより得られる
塩(C)との、少なくとも何れか一方を含有する皮膚用
化粧料。1. A salt (B) obtained by acidifying seawater, adding a basic solution to remove the formed precipitate, concentrating the obtained solution, cooling and filtering. ,
For skin containing at least one of salt (C) obtained by evaporating the solvent from the filtered solution
Cosmetics .
え、生成する沈殿物を除去した後、得られた溶液を濃縮
し、冷却後、濾別することにより得られる塩(B)と、
濾別された溶液から溶媒を蒸発することにより得られる
塩(C)との、少なくとも何れか一方を水に溶解させた
水溶液を含有する皮膚用化粧料。2. A salt (B) obtained by acidifying seawater, adding a basic solution to remove the formed precipitate, concentrating the resulting solution, cooling and filtering. ,
A skin cosmetic containing an aqueous solution in which at least one of salt (C) obtained by evaporating a solvent from the filtered solution is dissolved in water.
合計量が、0.1乃至2.0重量%含有することを特徴
とする請求項1又は2に記載の皮膚用化粧料。3. The skin cosmetic according to claim 1, wherein the total amount of both the salt (B) and the salt (C) is 0.1 to 2.0% by weight. Fee .
なくとも何れか一方を有することを特徴とする請求項1
乃至3の何れか一項に記載の皮膚用化粧料。4. The method of claim 1, characterized in that it comprises at least one of anti-aging effects and cell growth promoting action
4. The skin cosmetics according to any one of 3 to 3 .
または塩(C)を製造する方法であって、 海水を酸性にする第一の過程と、 塩基性溶液を加え、生成する沈殿物を除去する第二の過
程と、 前記第二の過程において得られた溶液を、濃縮し、冷却
後、濾別することにより得られる前記塩(B)を生成
し、または、濾別された溶液から溶媒を蒸発することに
より得られる前記塩(C)を生成する第三の過程と、 を備える、皮膚用化粧料の含有成分である塩(B)また
は塩(C)の製造方法。5. A salt (B) which is a component contained in a skin cosmetic.
Or a method for producing salt (C), which comprises a first step of acidifying seawater, a second step of adding a basic solution and removing a precipitate formed, and a step of obtaining the salt in the second step. The resulting solution is concentrated and cooled, and then the salt (B) is obtained by filtering, or the salt (C) is obtained by evaporating the solvent from the filtered solution. And a third step of: (3) A method for producing a salt (B) or a salt (C), which is a component contained in a skin cosmetic .
程と、 前記第二の過程において得られた溶液を、濃縮し、冷却
後、濾別することにより得られる塩(B)を生成し、ま
たは、濾別された溶液から溶媒を蒸発することにより得
られる塩(C)を生成する第三の過程と、 前記塩(B)および前記塩(C)の少なくとも何れか一
方を皮膚用化粧料に含有させる第四の過程と、 を備える皮膚用化粧料の製造方法。6. A method for producing a skin cosmetic , comprising a first step of acidifying seawater, a second step of adding a basic solution and removing a precipitate formed, and the second step of The solution obtained in the process is concentrated and cooled, and then filtered to form a salt (B), or the solvent is evaporated from the filtered solution to obtain a salt (C). third process and, at least one method for producing a skin cosmetic comprising a fourth step, the to one of the contained in the skin cosmetic of the salt (B) and the salts (C) to be generated.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000089577A JP3526806B2 (en) | 2000-03-28 | 2000-03-28 | Cosmetics |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000089577A JP3526806B2 (en) | 2000-03-28 | 2000-03-28 | Cosmetics |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001278767A JP2001278767A (en) | 2001-10-10 |
| JP3526806B2 true JP3526806B2 (en) | 2004-05-17 |
Family
ID=18605316
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000089577A Expired - Fee Related JP3526806B2 (en) | 2000-03-28 | 2000-03-28 | Cosmetics |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3526806B2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110981068B (en) * | 2019-12-25 | 2022-08-09 | 山东夙沙高科生物有限公司 | Preparation method of acidic water for cosmetics |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06256161A (en) * | 1993-02-26 | 1994-09-13 | Marine Bio Kk | Bathing agent |
| JP2708699B2 (en) * | 1993-06-30 | 1998-02-04 | 鐘紡株式会社 | Bath composition |
| IT1276322B1 (en) * | 1994-07-21 | 1997-10-28 | Vbc Srl | PROCEDURE FOR THE PURIFICATION OF MAGNESIUM HYDROXIDE |
| JPH08104607A (en) * | 1994-10-05 | 1996-04-23 | Kyotaro Hasunuma | Cosmetic |
| JPH08217631A (en) * | 1995-02-15 | 1996-08-27 | Kanebo Ltd | Powdery pack cosmetic |
| JPH10182412A (en) * | 1996-12-27 | 1998-07-07 | Kose Corp | External-use medical preparation |
| JP3055882B2 (en) * | 1996-12-27 | 2000-06-26 | 株式会社コーセー | Skin cosmetics |
| JPH10194732A (en) * | 1997-01-08 | 1998-07-28 | Masakazu Miyagi | Salt manufacture and salt |
| JPH1112154A (en) * | 1997-06-25 | 1999-01-19 | Kochi Pref Gov | Cosmetics |
| JP2000072656A (en) * | 1998-08-28 | 2000-03-07 | Kanebo Ltd | Bath cosmetic |
-
2000
- 2000-03-28 JP JP2000089577A patent/JP3526806B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2001278767A (en) | 2001-10-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2002100359A1 (en) | Preparation for hair and/or scalp | |
| US5955083A (en) | Use of eriobotrya japonica extract, in particular in cosmetics for stimulating glycosaminoglycan synthesis | |
| CN110623882A (en) | Whitening and freckle removing mask and preparation method thereof | |
| CN105496938B (en) | α-bisabolol shin moisturizer | |
| JPH06128121A (en) | Cosmetics | |
| KR20160131387A (en) | Composition for skin care | |
| JP2001163754A (en) | Anti-aging agent and cosmetic formulated therewith | |
| JPH08325130A (en) | Cosmetic | |
| US11918666B2 (en) | Topical formulations comprising strontium and methylsulfonylmethane (MSM) and methods of treatment | |
| JPH11315008A (en) | Antiaging agent | |
| US11045471B2 (en) | Melanin production inhibitor, whitening agent, fibroblast activator, collagen and/or elastin production promotor and wrinkle ameliorant | |
| JP3432175B2 (en) | Cell growth promotion cosmetics | |
| JPH1029927A (en) | Antiaging agent | |
| JP3278138B2 (en) | External preparation for skin | |
| JPH10212225A (en) | Wrinkle preventive | |
| JPH03112912A (en) | Cosmetic composition | |
| JP3526806B2 (en) | Cosmetics | |
| JP2000264834A (en) | Whitening cosmetics | |
| JP3505003B2 (en) | External preparation | |
| JPH05301812A (en) | Skin external preparation | |
| JP4221547B2 (en) | Composition containing retinoic acids or derivatives thereof | |
| JP2001199873A (en) | Composition for external use | |
| JP5226200B2 (en) | Sulfated glycosaminoglycan production promoter and skin external preparation containing the same | |
| JP3023543B2 (en) | Tyrosinase activity inhibitor and cosmetic | |
| TWI871483B (en) | Composition for brightening containing sodium pyruvate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20040212 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20040217 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
| R360 | Written notification for declining of transfer of rights |
Free format text: JAPANESE INTERMEDIATE CODE: R360 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R370 | Written measure of declining of transfer procedure |
Free format text: JAPANESE INTERMEDIATE CODE: R370 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
| R360 | Written notification for declining of transfer of rights |
Free format text: JAPANESE INTERMEDIATE CODE: R360 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080227 Year of fee payment: 4 |
|
| R370 | Written measure of declining of transfer procedure |
Free format text: JAPANESE INTERMEDIATE CODE: R370 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080227 Year of fee payment: 4 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080227 Year of fee payment: 4 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080227 Year of fee payment: 4 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080227 Year of fee payment: 4 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090227 Year of fee payment: 5 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090227 Year of fee payment: 5 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100227 Year of fee payment: 6 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100227 Year of fee payment: 6 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110227 Year of fee payment: 7 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110227 Year of fee payment: 7 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120227 Year of fee payment: 8 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130227 Year of fee payment: 9 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130227 Year of fee payment: 9 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140227 Year of fee payment: 10 |
|
| LAPS | Cancellation because of no payment of annual fees |